Physician profile
John M Baten
NPI 1114016144
$22,294.59
in general payments reported to CMS, 2019-2025
29 companies · $608 in 2025
The $608 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $7,144 · 2021: $602 · 2022: $401 · 2023: $547 · 2024: $1,115 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,770 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $435 · Gift: $63.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,770.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $435.00 |
| Gift | $63.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16,302.48 | 2019-2025 | Liletta, Botox |
| Baxter Healthcare | $1,524.97 | 2020 | |
| Medtronic, INC. | $1,172.76 | 2021-2025 | Interstim |
| Intuitive Surgical, INC. | $1,033.05 | 2019-2025 | Da Vinci Surgical System |
| Medtronic USA, INC. | $535.78 | 2019-2020 | |
| Mimedx Group, INC. | $435.00 | 2024 | |
| Astellas Pharma US INC | $248.28 | 2024-2025 | Veozah |
| Axonics, INC. | $247.98 | 2021-2024 | Bulkamid, Axonics |
| Davol INC. | $182.09 | 2022-2024 | Arista Ah Flexitip |
| Allergan, INC. | $82.06 | 2019-2021 | |
| Acessa Health INC. | $74.01 | 2019 | |
| Caldera Medical, INC | $63.94 | 2023 | Desara |
| Pfizer INC. | $56.32 | 2021-2024 | |
| Hologic Sales and Service, LLC | $49.84 | 2020-2024 | Novasure, Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $30.88 | 2021-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $27.57 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $25.41 | 2023 | Exparel |
| Takeda Pharmaceuticals U.S.A., INC. | $24.83 | 2022 | |
| Evofem Biosciences, INC. | $23.07 | 2021 | |
| Coloplast Corp | $21.91 | 2025 | |
| Lsi Solutions INC | $18.14 | 2025 | Fornisee |
| Daiichi Sankyo INC. | $17.34 | 2022 | |
| Coopersurgical, INC. | $15.99 | 2020 | |
| Boston Scientific Corporation | $15.22 | 2021 | |
| Organon LLC | $14.91 | 2022-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $13.85 | 2019 | |
| Smith+Nephew, INC. | $13.17 | 2022 | |
| Avion Pharmaceuticals | $11.97 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Baten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.